0
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Symptomatic uncomplicated diverticular disease: a critical appraisal

, , , ORCID Icon &
Received 19 Apr 2024, Accepted 01 Aug 2024, Accepted author version posted online: 02 Aug 2024
Accepted author version

REFERENCES

  • Stollman N, Raskin JB. Diverticular disease of the colon. The Lancet. 2004;363(9409):631–639. doi: 10.1016/S0140-6736(04)15597-9
  • Bharucha AE, Parthasarathy G, Ditah I, et al. Temporal trends in the incidence and natural history of diverticulitis: a population-based study. Am J Gastroenterol. 2015;110(11):1589–1596. doi: 10.1038/ajg.2015.302
  • Binda GA, Cuomo R, Laghi A, et al. Practice parameters for the treatment of colonic diverticular disease: Italian Society of Colon and rectal surgery (SICCR) guidelines. Tech Coloproctol. 2015;19(10):615–626. doi: 10.1007/s10151-015-1370-x
  • Cuomo R, Barbara G, Pace F, et al. Italian consensus conference for colonic diverticulosis and diverticular disease. United European Gastroenterology Journal. 2014;2:413.
  • Kruis W, Germer C-T, Böhm S, et al. German guideline diverticular disease/diverticulitis: part I: methods, pathogenesis, epidemiology, clinical characteristics (definitions), natural course, diagnosis and classification. United European Gastroenterol J. 2022;10(9):923–939. doi: 10.1002/ueg2.12309
  • Trifan A, Gheorghe C, Marica Sabo C, et al. Diagnosis and treatment of colonic diverticular disease: position paper of the romanian society of gastroenterology and hepatology. J Gastrointestin Liver Dis. 2018;27(4):449–457. doi: 10.15403/jgld.2014.1121.274.rom
  • Schultz JK, Azhar N, Binda GA, et al. European Society of Coloproctology: guidelines for the management of diverticular disease of the colon. Colorectal Dis. 2020;22 Suppl 2:5–28.
  • Peery AF, Keku TO, Addamo C, et al. Colonic diverticula are not associated with mucosal inflammation or chronic gastrointestinal symptoms. Clin Gastroenterol Hepatol. 2018;16(6):884–891.e1. doi: 10.1016/j.cgh.2017.05.051
  • Baethge C, Goldbeck-Wood S, Mertens S. SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4:5.
  • Latella G, Pimpo MT, Sottili S, et al. Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis. 2003;18(1):55–62. doi: 10.1007/s00384-002-0396-5
  • Brandimarte G, Tursi A. Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease. Med Sci Monit. 2004;10:PI70–73.
  • Clemens CHM, Samsom M, Roelofs J, et al. Colorectal visceral perception in diverticular disease. Gut. 2004;53:717–722.
  • Colecchia A, Vestito A, Pasqui F, et al. Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J Gastroenterol. 2007;13:264–269.
  • Annibale B, Maconi G, Lahner E, et al. Efficacy of Lactobacillus paracasei sub. paracasei F19 on abdominal symptoms in patients with symptomatic uncomplicated diverticular disease: a pilot study. Minerva Gastroenterol Dietol. 2011;57:13–22.
  • Annibale B, Lahner E, Maconi G, et al. Clinical features of symptomatic uncomplicated diverticular disease: a multicenter Italian survey. Int J Colorectal Dis. 2012;27(9):1151–1159. doi: 10.1007/s00384-012-1488-5
  • Kruis W, Meier E, Schumacher M, et al. Randomised clinical trial: mesalazine (salofalk granules) for uncomplicated diverticular disease of the colon–a placebo-controlled study. Aliment Pharmacol Ther. 2013;37(7):680–690. doi: 10.1111/apt.12248
  • Tursi A, Brandimarte G, Elisei W, et al. Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease–a double-blind, randomised, placebo-controlled study. Aliment Pharmacol Ther. 2013;38:741–751.
  • Tursi A, Elisei W, Picchio M, et al. Moderate to severe and prolonged left lower-abdominal pain is the best symptom characterizing symptomatic uncomplicated diverticular disease of the colon: a comparison with fecal calprotectin in clinical setting. J Clin Gastroenterol. 2015;49(3):218–221. doi: 10.1097/MCG.0000000000000094
  • Barbara G, Scaioli E, Barbaro MR, et al. Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease. Gut. 2017;66(7):1252–1261. doi: 10.1136/gutjnl-2016-312377
  • Kvasnovsky CL, Leong LEX, Choo JM, et al. Clinical and symptom scores are significantly correlated with fecal microbiota features in patients with symptomatic uncomplicated diverticular disease: a pilot study. Eur J Gastroenterol Hepatol. 2018;30(1):107–112. doi: 10.1097/MEG.0000000000000995
  • Pietrzak AM, Banasiewicz T, Skoczylas K, et al. Combined therapy: rifaximin-α and arabinogalactan with lactoferrin combination effectively prevents recurrences of symptomatic uncomplicated diverticular disease. Pol Przegl Chir. 2020;92(2):22–28. doi: 10.5604/01.3001.0014.0946
  • Tursi A, Franceschi M, Elisei W, et al. The natural history of symptomatic uncomplicated diverticular disease: a long-term follow-up study. Ann Gastroenterol. 2021;34:208–213.
  • Tursi A, Elisei W, Franceschi M, et al. The prevalence of symptomatic uncomplicated diverticular disease could be lower than expected: a single-center colonoscopy-based cohort study. Eur J Gastroenterol Hepatol. 2021;33(1S):e478–e483. doi: 10.1097/MEG.0000000000002142
  • Peery AF, Keku TO, Galanko JA, et al. Colonic Diverticulosis Is Not Associated With Painful Abdominal Symptoms in a US Population. Gastro Hep Adv. 2022;1:659–665.
  • Maconi G, Dell’era A, Flor N, et al. Ultrasonographic and functional features of symptomatic uncomplicated diverticular disease. Clin Transl Gastroenterol. 2023;14(6):e00580. doi: 10.14309/ctg.0000000000000580
  • Jono T, Kasai Y, Kessoku T, et al. The prevalence and characteristics of symptomatic uncomplicated diverticular disease among Asian patients with unexplained abdominal symptoms. J Neurogastroenterol Motil. 2024;30(1):87–96. doi: 10.5056/jnm22162
  • Santacroce G, Lenti MV, Abruzzese GM, et al. Diagnostic delay in symptomatic uncomplicated diverticular disease: an Italian tertiary referral centre study. Intern Emerg Med. 2024;19(1):99–106. doi: 10.1007/s11739-023-03446-x
  • Carabotti M, Marasco G, Sbarigia C, et al. Site and duration of abdominal pain discriminate symptomatic uncomplicated diverticular disease from previous diverticulitis patients. Intern Emerg Med. 2024;10.1007/s11739-024-03588-6
  • Lahat A, Necula D, Yavzori M, et al. Prolonged recurrent abdominal pain is associated with ongoing underlying mucosal inflammation in patients who had an Episode of Acute Complicated Diverticulitis. J Clin Gastroenterol. 2019;53(5):e178–e185. doi: 10.1097/MCG.0000000000000980
  • Ballou S, Singh P, Nee J, et al. Prevalence and associated factors of bloating: results from the rome foundation global epidemiology study. Gastroenterology. 2023;165(3):647–655.e4. doi: 10.1053/j.gastro.2023.05.049
  • Pietrzak A, Bartnik W, Szczepkowski M, et al. Polish interdisciplinary consensus on diagnostics and treatment of colonic diverticulosis (2015). Pol Przegl Chir. 2015;87(4):203–220. doi: 10.1515/pjs-2015-0045
  • Mearin F, Lacy BE, Chang L, et al. Bowel Disorders. Gastroenterology. 2016;S0016-5085(16 )00222-5.
  • Săftoiu A, Hassan C, Areia M, et al. Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: european society of gastrointestinal endoscopy (ESGE) position statement. Endoscopy. 2020;52(4):293–304. doi: 10.1055/a-1104-5245
  • Spiller R. Diverticular Disease and IBS: Overlapping or Misunderstanding? J Clin Gastroenterol. 2016;50 Suppl 1:S29–32.
  • Calini G, Abd El Aziz MA, Paolini L, et al. Symptomatic Uncomplicated Diverticular Disease (SUDD): Practical Guidance and Challenges for Clinical Management. Clin Exp Gastroenterol. 2023;16:29–43. 10.2147/CEG.S340929
  • Spiller R. Is it diverticular disease or is it irritable bowel syndrome? Dig Dis. 2012;30(1):64–69. doi: 10.1159/000335721
  • Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study. Gastroenterology. 2021;160(1):99–114.e3. doi: 10.1053/j.gastro.2020.04.014
  • Carabotti M, Cuomo R, Barbara G, et al. Demographic and clinical features distinguish subgroups of diverticular disease patients: results from an Italian nationwide registry. United European Gastroenterol J. 2018;6(6):926–934. doi: 10.1177/2050640618764953
  • Cuomo R, Barbara G, Andreozzi P, et al. Symptom patterns can distinguish diverticular disease from irritable bowel syndrome. Eur J Clin Invest. 2013;43(11):1147–1155. doi: 10.1111/eci.12152
  • Tursi A, Brandimarte G, Elisei W, et al. Faecal calprotectin in colonic diverticular disease: a case-control study. Int J Colorectal Dis. 2009;24:49–55.
  • Spiller R, Campbell E. Post-infectious irritable bowel syndrome. Curr Opin Gastroenterol. 2006;22(1):13–17. doi: 10.1097/01.mog.0000194792.36466.5c
  • Lahat A, Fidder HH, Ben-Horin S Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort. Therap Adv Gastroenterol. 2020;13:1756284820913210.10.1177/1756284820913210
  • Galli G, Carabotti M, Pilozzi E, et al. Relationship between persistent gastrointestinal symptoms and duodenal histological findings after adequate gluten-free diet: a gray area of celiac disease management in adult patients. Nutrients. 2021;13(2):600. doi: 10.3390/nu13020600
  • Lusetti F, Schiepatti A, Scalvini D, et al. Efficacy of a low-FODMAP diet for coeliac patients with persistent IBS-like symptoms despite a gluten-free diet: a systematic review. Nutrients. 2024;16(7):1094. doi: 10.3390/nu16071094
  • Silvester JA, Graff LA, Rigaux L, et al. Symptoms of functional intestinal disorders are common in patients with celiac disease following transition to a gluten-free diet. Dig Dis Sci. 2017;62(9):2449–2454. doi: 10.1007/s10620-017-4666-z
  • Usai-Satta P, Bassotti G, Bellini M, et al. Irritable bowel syndrome and gluten-related disorders. Nutrients. 2020;12(4):1117. doi: 10.3390/nu12041117
  • Colombel J-F, Shin A, Gibson PR. AGA clinical practice update on functional gastrointestinal symptoms in patients with inflammatory bowel disease: expert review. Clin Gastroenterol Hepatol. 2019;17(3):380–390.e1. doi: 10.1016/j.cgh.2018.08.001
  • Jonefjäll B, Strid H, Öhman L, et al. Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission. Neurogastroenterology & Motility. 2013;25:756–e578.
  • Kruis W, Germer C-T, Böhm S, et al. German guideline diverticular disease/diverticulitis: part II: conservative, interventional and surgical management. United European Gastroenterol J. 2022;10(9):940–957. doi: 10.1002/ueg2.12313

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.